echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nano flu vaccine protects against seasonal flu

    Nano flu vaccine protects against seasonal flu

    • Last Update: 2022-05-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    According to a recent study, researchers have developed an experimental flu vaccine that protects animals from a variety of seasonal and pandemic strains of the flu

    The vaccine is currently entering clinical trials

    If proven safe and effective, these next-generation flu vaccines could replace current seasonal options by providing protection against more strains that current vaccines cannot adequately cover

    A study published March 24 in the journal Nature details how new flu vaccines are designed and how they protect mice, ferrets and non-human primates

    The work was led by researchers at the University of Washington School of Medicine and members of the Center for Vaccine Research at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health

    An estimated 290,000 to 650,000 people have now died from the flu virus
    Existing flu vaccines require seasonal use and generally do not protect against multiple circulating flu strains

    "Most flu vaccines are now quadrivalent, which means they are made from four different flu strains

    The World Health Organization predicts the four most prevalent flu strains each year, but those predictions may be more or less That

    's why we often get 'mismatched' flu vaccines that still work, but only partially," said Daniel Ellis, a research scientist in the lab of Neil King, assistant professor of biochemistry at the UW School of Medicine.


    To create an improved version of the flu vaccine, the team attached the hemagglutinin proteins from four different influenza viruses to custom-made nanoproteins

    This approach allows unprecedented control over the molecular structure of the resulting vaccine and produces a better immune response than conventional flu vaccines

    The new nanoparticle vaccine contains the same four hemagglutinin proteins as the commercial quadrivalent influenza vaccine and produces the same or better response to the vaccine-matched strain in mice, ferrets and non-human primates as the commercial vaccine , which can neutralize the antibody response

    Nanovaccines (but not commercial vaccines) can also induce protective antibody responses against viruses not included in the vaccine formulation

    "Our vaccine does have a strong response to strain-matched viruses, and we see that additional coverage for mismatched strains can reduce risk during flu season," Ellis said

    refer to:

    Seyhan Boyoglu-Barnum, Daniel Ellis, Rebecca A.
    Gillespie et al, Quadrivalent influenza nanoparticle vaccines induce broad protection, Nature (2021).
    DOI: 10.

    Nature: Nano flu vaccine protects against seasonal flu

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.